These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3223421)

  • 1. Quantitative abnormalities of lipoprotein particles in chronic hemodialysis patients.
    Parra HJ; Cachera C; Equagoo K; Dracon M; Fruchart JC; Tacquet A
    Adv Exp Med Biol; 1988; 243():283-7. PubMed ID: 3223421
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased lipoprotein-remnant formation in chronic renal failure.
    Nestel PJ; Fidge NH; Tan MH
    N Engl J Med; 1982 Aug; 307(6):329-33. PubMed ID: 7088097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.
    Samuelsson O; Attman PO; Knight-Gibson C; Kron B; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1997; 75(3):286-94. PubMed ID: 9069450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
    Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
    Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid and lipoprotein abnormalities in children on hemodialysis and after renal transplantation.
    Van Gool S; Van Damme-Lombaerts R; Cobbaert C; Proesmans W; Eggermont E
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1375-7. PubMed ID: 1989241
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM; Knight-Gibson C; Samuelsson O; Attman PO; Wang CS; Alaupovic P
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dialysis on lipid metabolism in chronic renal failure - acetate versus bicarbonate.
    Kobayashi N; Okubo M; Marumo F; Nakamura H
    Int J Artif Organs; 1983 Jul; 6(4):187-90. PubMed ID: 6414954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of two low-flux cellulose acetate dialysers on plasma lipids and lipoproteins--a cross-over trial.
    Ingram AJ; Parbtani A; Churchill DN
    Nephrol Dial Transplant; 1998 Jun; 13(6):1452-7. PubMed ID: 9641175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI).
    Kimak E; Solski J; Janicka L; Zagojska M
    Int Urol Nephrol; 1999; 31(2):263-7. PubMed ID: 10481973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term haemodialysis on lipid, lipoprotein and apolipoprotein levels of black patients with chronic renal failure.
    Rifai N; King ME; Sica DA
    Ann Clin Biochem; 1988 May; 25 ( Pt 3)():242-5. PubMed ID: 3400979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein B-containing lipoprotein particles in progressive renal insufficiency.
    Attman PO; Tavella M; Knight-Gibson C; Samuelsson O; Alaupovic P
    Contrib Nephrol; 1992; 98():11-9. PubMed ID: 1493721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Levels of serum lipids and lipoproteins in renal disease].
    Synková J; Groh J; Sedová J; Mejtská M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(3):373-84. PubMed ID: 6977835
    [No Abstract]   [Full Text] [Related]  

  • 13. Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.
    Parra HJ; Mezdour H; Cachera C; Dracon M; Tacquet A; Fruchart JC
    Clin Chem; 1987 May; 33(5):721. PubMed ID: 2952378
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in glucose tolerance, insulin, serum lipids and lipoproteins in patients with renal failure on intermittent haemodialysis.
    Arora KK; Atkinson MK; Trafford JA; Sheldon J; Nunn R
    Postgrad Med J; 1973 May; 49(571):293-6. PubMed ID: 4804451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased concentrations of Apo B-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure.
    Attman PO; Knight-Gibson C; Tavella M; Samuelsson O; Alaupovic P
    Miner Electrolyte Metab; 1992; 18(2-5):199-202. PubMed ID: 1465058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of serum magnesium and serum lipid levels in hemodialysis patients.
    Robles NR; Escola JM; Albarran L; Espada R
    Nephron; 1998; 78(1):118-9. PubMed ID: 9453415
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein and apoprotein levels in different types of dialysis.
    Cassader M; Ruiu G; Tagliaferro V; Triolo G; Pagano G
    Int J Artif Organs; 1989 Jul; 12(7):433-8. PubMed ID: 2767788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipoprotein abnormalities in hemodialysis patients.
    Aatif T; Asseraji M; Maoujoud O; Dami A; El Allam M; Oualim Z
    Saudi J Kidney Dis Transpl; 2012 Nov; 23(6):1281-4. PubMed ID: 23168866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.